- Home
- About Us
- Divisions
- Adolescent and Young Adult Medicine
- Allergy and Immunology
- Blood and Marrow Transplantation and Cellular Therapies
- Cardiology
- Child Advocacy
- Emergency Medicine
- Endocrinology
- Gastroenterology, Hepatology and Nutrition
- General Academic Pediatrics
- Genetic and Genomic Medicine
- Health Informatics
- Hematology-Oncology
- Infectious Diseases
- Nephrology
- Neurology and Child Development
- Newborn Medicine
- Paul C. Gaffney Division of Pediatric Hospital Medicine
- Pulmonology
- Rheumatology
- Centers & Institutes
- Center for Pediatric Research in Obesity and Metabolism
- Center for Rare Disease Therapy
- Children's Neuroscience Institute
- Cystic Fibrosis Research Center
- Institute for Infection, Inflammation, and Immunity in Children
- Pediatric Asthma Center
- Pediatric Institute for Heart Regeneration and Therapeutics
- Richard King Mellon Foundation Institute for Pediatric Research
- Pittsburgh Vaccine Trials Unit
- The Pittsburgh Study
- Research
- Diversity
- Education
- Faculty Affairs
- News
- People
- Podcasts
Edward V. Prochownik, MD, PhD
- Paul C. Gaffney Professor of Pediatrics and Professor of Microbiology and Molecular Genetics
Administrative Assistant: Carla Clarke
Education & Training
- BA, Biology, Johns Hopkins University, 1972
- PhD, Pathology/Virology, University of Chicago, 1977
- MD, University of Chicago-Pritzker School of Medicine, 1978
- Internship in Pediatrics, Boston Children's Hospital, 1978-1979
- Junior Assistant Resident in Pediatrics, Boston Children's Hospital, 1979-1980
- Clinical Fellow in Pediatric Hematology-Oncology, The Children's Hospital and Dana Farber Cancer Institute-Harvard Medical School, 1980-1981
- Research Fellow in Pediatric Hematology-Oncology, The Children's Hospital and Dana Farber Cancer Institute-Harvard Medical School, 1981-1983
Selected Publications
Academic and Research Interests
- Cancer Genetics
- Hepatoblastoma
- Hepatocellular Carcinoma
- Tumor Supressors
- Myc Oncogene
- Cancer Metabolism
- Cancer and Aging
- Pediatric Cancer
Research Grants
1RO1 CA174713, Control of Metabolism and Energy-Sensing Pathways by c-Myc, Funding Agency: NIH, PI, 07/01/14-6/30/19, 10% effort, $1,638,864
Project 1: Pre-Clinical and Clinical Imaging and Treatment of Multiple Myeloma with C-Myc-Max Nanoparticles, NIH, PI: Gregory Lanza, MD (Washington Univ. School of Medicine), 9/1/15-8/31/20, 10% effort, $396,705
522000 Ribosomopathy-like properties of Cancers, Hyundai Hope on Wheels (Hyundai Corp.), PI, 6/1/17-5/31/19, 10% effort, $250,000
Patient-Derived NFE2L2/NRF2 Mutations Promote Aggressive Forms of Hepatoblastoma, The V Foundation, PI, 9/1/20-8/31/21, 10% effort, $150,000